Find effective medications for 'Schizophrenia treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to manage ...

British drug companies are making a new assault on schizophrenia, with about 16 novel medicines in the pipeline. A number of experimental drugs are designed to alter the chemistry of brain regions ...

BMS said Cobenfy will be available in October at a list price of $1,850 per month ... the price is in line with other antipsychotic schizophrenia medications. The company is investigating whether ...

Some participants said the drug reduced the voices while others said it didn't work for them. The estimated yearly cost for Cobenfy is $22,500 compared to $540 for a generic antipsychotic.

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia ... of all marketed drugs, and Boehringer adds to a growing list of partners that ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...

DelveInsight’s, “Schizophrenia Pipeline Insight” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Schizophrenia pipeline landscape. It covers the ...